Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017 by Bob Yirka, Medical Xpress report

Credit: Baylor College of Medicine
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with the metastasizing cells. In their paper published in the journal Science, the group describes their study of the bacteria and its possible link to being a cause of colon cancer.

Prior research has shown that bacteria exist alongside for various types of cancers, causing some in the medical field to wonder if they are actually the cause of . One such type of bacteria, Fusobacterium nucleatum, has been found to exist alongside colon cancer tumor cells. In this new effort, the researchers wondered if the same bacteria might exist alongside colon cancer tumor cells that have migrated to another part of the body, specifically, the liver.

To find out, the researchers collected tissue samples from actual patients. In so doing, they found that in many cases the same strain of bacteria was present in tumors in both the colon and liver in patients where the cancer had metastasized. They also found that patients who had colon cancer but had no evidence of the bacteria in their tumors, also did not have the bacteria in their .

Intrigued by the findings, the researchers implanted tumors from human patients into healthy rats. In so doing they found that those tumors which also had the bacteria took hold and began growing. Those tumors that did not have the bacteria, on the other hand, failed to take hold. The team next tested the possibility of treating the in mice by treating them with an antibiotic known to kill F. nucleatum. They found that doing so did indeed slow the growth of the tumor.

In looking at all of their findings, the suggest that it appears that the bacteria do travel with the tumor cells to a new site and remain with new tumors that develop in those sites. They suggest further that it might be possible that the bacteria aides in colonization at the new site. More research will be done, of course, to determine if the actually play a role in the development of tumors.

Explore further: Bacteria protect intestinal tumor model from being killed by immune cells

More information: Susan Bullman et al. Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer, Science (2017). DOI: 10.1126/science.aal5240

Abstract
Colorectal cancers comprise a complex mixture of malignant cells, non-transformed cells and microorganisms. Fusobacterium nucleatum is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of human colorectal cancers with Fusobacterium and its associated microbiome, including Bacteroides, Selenomonas and Prevotella species, is maintained in distal metastases, demonstrating microbiome stability between paired primary-metastatic tumors. In situ hybridization analysis revealed that Fusobacterium is predominantly associated with cancer cells in the metastatic lesions. Mouse xenografts of human primary colorectal adenocarcinomas were found to retain viable Fusobacterium and its associated microbiome through successive passages. Treatment of mice bearing a colon cancer xenograft with the antibiotic metronidazole reduced Fusobacterium load, cancer cell proliferation and overall tumor growth. These observations argue for further investigation of antimicrobial interventions as a potential treatment for patients with Fusobacterium-associated colorectal cancer.

Related Stories

Bacteria protect intestinal tumor model from being killed by immune cells

February 11, 2015
Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February ...

Genetically altered bacteria help destroy cancerous tumors in mice

February 9, 2017
(Medical Xpress)—A team of researchers affiliated with multiple institutions in Korea has found that genetically altering a type of bacteria and injecting it into cancerous mice resulted in the disappearance of tumors in ...

Scientists find bacteria in pancreatic tumors that metabolize a common drug

September 15, 2017
To the reasons that chemotherapy sometimes does not work, we can now add one more: bacteria. In a study published today in Science, researchers describe findings that certain bacteria can be found inside human pancreatic ...

Rat study shows gut microbes play a role in colon cancer susceptibility

July 13, 2016
The microscopic organisms that live in our gut do more than help us digest food. A new study in rats bolsters a growing body of evidence that the complex mix of microorganisms found in the gut, known as gut microbiota, could ...

AZD6738 found to slow some types of children's tumor growth in mouse models

November 2, 2017
(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type tumor growths in mouse models. In their paper published in the journal Science ...

How mouth microbes may worsen colorectal cancer

August 10, 2016
Bacteria commonly found in the mouth have been recently shown to worsen colorectal cancer in animals, but it has not been clear how these microbes make their way to the gut in the first place. A study published August 10 ...

Recommended for you

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

LaPortaMA
not rated yet Nov 25, 2017
Strep D/Strep faecalis known for decades.
Chris_Reeve
Nov 26, 2017
This comment has been removed by a moderator.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.